AmpliVue Trichomonas Assay
Trichomonas Vaginalis Nucleic Acid Amplification Test System. 510(k) K143329, from Quidel Corporation (Athens, OH). Product code OUY, class 2.
As of Nov 22, 2026, K143329 is an FDA 510(k) held by Quidel Corporation, substantially equivalent on Mar 17, 2015 after 117 days, with no recalls tied to it in FDA's recall database.
- Review time: 117 days
- Recalls: 0
- Cited as a predicate by: 1 device
The AmpliVue® Trichomonas Assay is an in vitro diagnostic test, uses isothermal amplification technology (helicase- dependent amplification, HDA) for the qualitative detection of Trichomonas vaginalis nucleic acids isolated from clinician-collected vaginal swab specimens obtained from symptomatic or asymptomatic females to aid in the diagnosis of trichomoniasis.
- Aptima Trichomonas Vaginalis Assay - PantherK122062 · Gen-Probe, Inc. · Jan 9, 2013
- Solana Trichomonas AssayK161182 · Quidel Corporation · Aug 15, 2016
- Aptima Trichomonas vaginalis AssayK231316 · Hologic, Inc. · Nov 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 20, 2014
- Review panel
- Immunology
- Regulation
- 21 CFR 866.3860
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files